
-
US Republicans close in on make-or-break Trump mega-bill vote
-
Arsenal sign goalkeeper Kepa from Chelsea
-
Olympic champion Zheng knocked out of Wimbledon
-
Line judges missed at Wimbledon as AI takes their jobs
-
Tshituka to make Test debut as Springboks change five
-
'Remember Charlie Hebdo!' Protesters seethe at Istanbul magazine
-
Top seed Sinner eases into Wimbledon second round
-
Stocks retreat as profit-taking follows Wall Street records
-
Israel expands campaign in Gaza ahead of Netanyahu's US visit
-
Barcelona's Ansu Fati aims to kick-start career in Monaco
-
Bordeaux-Begles drawn with Northampton in Champions Cup final repeat
-
Sean Combs trial: jurors seek verdict for a second day
-
Trump says will 'take a look' at deporting Musk
-
Greece starts charging tourist tax on cruises
-
Trump heads for 'Alligator Alcatraz' migrant detention center
-
US Senate push to pass Trump's unpopular spending bill enters second day
-
England captain Stokes relishing Pant battle in India series
-
Ukraine hits Russian city deep behind front line, leaves three dead
-
Hinault backs 'complete rider' Pogacar for Tour de France glory
-
Third seed Pegula suffers shock Wimbledon exit
-
Stocks struggle tracking US trade deal prospects
-
Djokovic launches Grand Slam history bid at Wimbledon
-
UK arrests three in Lucy Letby hospital probe
-
Europe on high alert as surprise early heatwave creeps north
-
UK govt faces major rebellion in welfare vote
-
Indian capital bans fuel for old cars in anti-pollution bid
-
Flintoff rules himself out of top England coaching job
-
Russia ramps up drone strikes on Ukraine in June: AFP analysis
-
Japan had hottest June on record: weather agency
-
Asian stocks rise on trade deal hopes, Tokyo hit by Trump warning
-
Thailand's PM suspended by Constitutional Court
-
Blur will return to musical oasis, says drummer Rowntree
-
CBEX crypto scam: AI-hyped Ponzi scheme defrauds African investors
-
Inzaghi hails 'extraordinary' Al Hilal after City upset
-
Man City, Inter Milan crash out of Club World Cup in last 16
-
North Korea's Kim shown honouring troops killed in Russia-Ukraine war
-
Saudi's Al Hilal knock Man City out of Club World Cup in huge shock
-
'In our blood': Egyptian women reclaim belly dance from stigma
-
Online memorial for children dead in Hiroshima, Nagasaki
-
US Senate in final push to pass Trump spending bill
-
Asian stocks rise on trade deal hopes, Tokyo hit by tariff warning
-
Hong Kong rights record under fire as it marks China handover anniversary
-
Bangladeshis cling to protest dreams a year after revolution
-
Djokovic, Sinner enter Wimbledon fray
-
European security tops Denmark's EU presidency priorities
-
France expecting peak temperatures as heatwave hits Europe
-
Germany eye return to women's football summit at Euro 2025
-
'Every day I see land disappear': Suriname's battle to keep sea at bay
-
England feel pressure to perform at Euros as stars pull out
-
Clashes in Istanbul over alleged 'Prophet Mohammed' cartoon

US court keeps abortion drug available -- for now
A US appeals court has blocked moves to ban a widely-used abortion pill -- but imposed tough restrictions on access, in the latest round of an intensifying battle over reproductive rights.
The ruling issued late Wednesday preserves access for now to mifepristone -- used for more than half of all abortions in the United States -- but a question mark remains over its long-term availability in a case likely to go all the way to Supreme Court.
The new order limits access to women in the first seven weeks of pregnancy, down from 10; it requires in-person visits to obtain the pill -- a requirement lifted in recent years; and it blocks the medication from being sent by mail.
Wednesday's 2-1 ruling by a federal appeals court in New Orleans, Louisiana, came after a Texas judge overturned the Food and Drug Administration's (FDA) two-decades old approval of the drug last Friday.
The appellate court said its ruling would hold until the case was heard in full -- likely by the Supreme Court.
The latest standoff over women's reproductive freedom in America comes almost a year after the conservative-dominated Supreme Court overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
- 'Commitment to women' -
US President Joe Biden has branded the Texas ruling as "out of bounds," and his spokeswoman, Karine Jean-Pierre, said Thursday the administration would continue fighting it in court.
"We believe that the law is on our side, and we will prevail," she told reporters during the president's visit to Dublin, Ireland.
"I can reassure the American people that that is our commitment to women ... to make sure that women are able to make decisions for themselves about their own body," she added.
Democrats and activists warn the Texas ruling -- issued by a judge appointed by former Republican president Donald Trump -- moves the nation one step closer to a nationwide abortion ban sought by many conservatives.
Judge Matthew Kacsmaryk's ruling came after a coalition of anti-abortion groups sued to freeze the national distribution of mifepristone.
The Texas judge, in his decision, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access the procedure -- or ban it outright.
The two New Orleans judges who voted to tighten restrictions on access, Kurt Engelhardt and Andrew Oldham, were also both appointed by Trump.
The third, Catharina Haynes, is an appointee of former president George W. Bush.
Shortly after the initial Texas decision, a judge in Washington state ruled in a separate case that access to mifepristone must be preserved. The dueling opinions, along with the appeals, mean the issue is almost certain to end up before the Supreme Court.
P.Mathewson--AMWN